In patient tissues, as PCa progressed, LDHA activity increased significantly in tissue samples from the T2 and T3 stages, compared to BPH (P < 0.01) (Figure 4D), which was associated with SIRT5 reduction (Figure 1E). The gene discussed is LDHA; the disease is benign prostatic hyperplasia.